FLOWERS FOODS INC·4

Jun 1, 3:54 PM ET

Casey Edward J. Jr. 4

4 · FLOWERS FOODS INC · Filed Jun 1, 2026

Research Summary

AI-generated summary of this filing

Updated

Flowers Foods (FLO) Director Casey Edward J. Jr. Exercises 9,350 Shares

What Happened Casey Edward J. Jr., a director of Flowers Foods, reported an exercise/conversion of derivative awards (transaction code M) for 9,350 shares on 2026-05-29. The Form 4 shows an "Acquired" entry and a corresponding "Disposed" entry for 9,350 shares at $0.00; footnotes indicate these were deferred shares with no conversion/exercise price and were granted under the company’s 2014 Omnibus Equity and Incentive Compensation Plan (Amended May 25, 2023). No cash proceeds or open-market sale value is reported.

Key Details

  • Transaction date: 2026-05-29; filing date: 2026-06-01 (filed within the two-business-day requirement).
  • Reported amounts: 9,350 shares acquired via exercise/conversion; 9,350 shares shown as disposed (derivative), price $0.00.
  • Transaction code: M = exercise or conversion of derivative securities.
  • Footnotes: F1 = granted under the 2014 Omnibus plan (amended May 25, 2023); F2 = deferred shares have no conversion/exercise price; F3 = no expiration date.
  • Shares owned after the transaction are not provided in the excerpt supplied.

Context This filing documents the conversion of deferred/share-based compensation rather than a cash purchase or an open-market sale. Such conversions are typically administrative (vesting/conversion of deferred awards) and do not necessarily signal new buying or selling intent by the insider.

Insider Transaction Report

Form 4
Period: 2026-05-29
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-29+9,35042,190 total
  • Exercise/Conversion

    Deferred Stock

    [F1][F2][F3]
    2026-05-299,3500 total
    Exercise: $0.00From: 2026-05-29Common Stock (9,350 underlying)
Footnotes (3)
  • [F1]Granted under the Flowers Foods, Inc. 2014 Omnibus Equity and Incentive Compensation Plan (Amended and Restated Effective May 25, 2023).
  • [F2]In accordance with the terms of the Deferred Shares Agreement for Directors, the deferred shares awarded do not have a conversion or exercise price.
  • [F3]No expiration date.
Signature
/s/ Stephanie B. Tillman, Agent|2026-06-01

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT